Inhibitors of type 2 vascular endothelial growth factor receptors
US7858739B2 · kind B2 · utility
62Cited by
20References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2006 |
| Grant date | Dec 28, 2010 |
| Priority date | — |
| Expiry date | Nov 19, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/43
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.